Thyroid & Parathyroid Surgery Nursing Guide

Thyroid Surgery Overview

Types of Thyroid Surgery

Total Thyroidectomy

Complete removal of both thyroid lobes and the isthmus.

Indications:

Differentiated thyroid cancer (papillary/follicular)
Bilateral or large multinodular goitre (MNG)
Graves' disease (refractory to medical/RAI therapy)
Large compressive goitre with tracheal deviation
Medullary thyroid cancer (MTC)

Consequence: Lifelong levothyroxine replacement mandatory.

Hemithyroidectomy / Thyroid Lobectomy

Removal of one lobe ± isthmus.

Indications:

Unilateral thyroid nodule (benign or low-risk cancer)
Low-risk papillary microcarcinoma (<1 cm, no extrathyroidal extension)
Unilateral MNG causing symptoms
Diagnostic excision when FNA is indeterminate

Note: Up to 30% will eventually need thyroxine replacement.

Pre-Operative Assessment

Thyroid Function — Must Be Euthyroid Before Surgery

Key Rule: Operating on a hyperthyroid patient risks thyroid storm. Ensure TSH, free T4, free T3 are within normal limits pre-operatively.

Graves' Disease Pre-Op Preparation

Antithyroid drugs (carbimazole/propylthiouracil) — render euthyroid (4-8 weeks)
Propranolol (beta-blocker) — controls sympathetic symptoms (tremor, tachycardia), continued up to and including day of surgery
Lugol's iodine (potassium iodide solution) — given 10-14 days pre-op; reduces thyroid vascularity and gland size (Wolff–Chaikoff effect), reducing intraoperative bleeding
Dose: 5-10 drops (0.1-0.3 mL) three times daily in water

General Pre-Op Assessment

Thyroid function tests (TSH, free T4, free T3)
Serum calcium and PTH baseline
Vitamin D level (especially GCC patients — high deficiency rate)
Coagulation screen
Neck USS and CT/MRI if retrosternal extension
FNAC cytology results review
Vocal cord assessment pre-operatively (see below)

Airway Assessment — Critical

AIRWAY PRIORITY: Thyroid disease can significantly distort the airway. Anaesthetic team must be alerted to all findings below.

Tracheal Deviation

Large goitre can displace or compress the trachea
Assess clinically and on imaging (CT neck/chest)
Tracheomalacia risk if longstanding compression
May require awake fibreoptic intubation

Stridor Assessment

Inspiratory stridor = upper airway obstruction
Can indicate tracheal compression from goitre
Urgent airway assessment if new-onset stridor
Peak flow measurement if able

Indirect Laryngoscopy

Performed pre-operatively by surgical team
Documents baseline vocal cord function
Identifies pre-existing RLN palsy (malignant invasion)
Mandatory before any thyroid/parathyroid surgery
Repeated post-operatively to assess RLN injury

Surgical Anatomy — Structures at Risk

Recurrent Laryngeal Nerve (RLN)

Runs in tracheo-oesophageal groove, deep to thyroid
Supplies all intrinsic laryngeal muscles except cricothyroid
Right RLN loops around subclavian artery; left loops around aortic arch
Non-recurrent RLN (rare right-sided anomaly — associated with aberrant subclavian)
Injury: Unilateral = hoarseness; Bilateral = stridor, respiratory distress

Superior Laryngeal Nerve (SLN)

External branch — supplies cricothyroid muscle (voice pitch)
Injury = loss of high-pitched phonation, voice fatigue
Commonly injured in superior pole dissection

Parathyroid Glands

Four glands (superior and inferior pairs) — highly variable position
Superior parathyroids: consistent, posterior to upper thyroid lobe
Inferior parathyroids: variable — can be anywhere from angle of jaw to mediastinum
Average size: 3-5 mm, weight 30-40 mg each
Blood supply from inferior thyroid artery (delicate, easily disrupted)
Devascularisation/inadvertent removal = post-op hypoparathyroidism → hypocalcaemia
Autotransplantation into sternocleidomastoid if inadvertently removed

Summary Table — Procedure Selection

Condition	Preferred Surgery	Notes
Papillary thyroid cancer >1 cm	Total thyroidectomy	Enables RAI; thyroglobulin monitoring
Papillary microcarcinoma <1 cm	Lobectomy acceptable	Active surveillance also an option
Follicular thyroid cancer	Total thyroidectomy	Often needs completion after lobectomy
Medullary thyroid cancer	Total thyroidectomy + central neck dissection	Check RET, calcitonin, CEA
Graves' disease	Total thyroidectomy	Pre-op Lugol's + propranolol
Multinodular goitre (bilateral)	Total thyroidectomy	Recurrence risk with subtotal
Solitary thyroid nodule (benign)	Hemithyroidectomy	Diagnostic + therapeutic

Post-Operative Monitoring

THREE CRITICAL POST-THYROIDECTOMY EMERGENCIES: (1) Wound Haematoma — expanding neck swelling; (2) Bilateral RLN injury — stridor; (3) Severe hypocalcaemia — laryngospasm/tetany. Know the immediate actions for each.

Recurrent Laryngeal Nerve Injury

Unilateral RLN Injury (1-2%)

Hoarseness, breathy voice, reduced cough effectiveness
Weak or absent voice in severe cases
Usually apparent immediately post-extubation
May be temporary (neurapraxia) or permanent
Action: Speech and language therapy referral, voice rest, ENT review, laryngoscopy

Bilateral RLN Injury — EMERGENCY

STRIDOR POST-EXTUBATION = BILATERAL RLN PALSY UNTIL PROVEN OTHERWISE
Both cords adduct to midline → near-complete airway obstruction
Action: Call airway team IMMEDIATELY. Prepare for emergency reintubation or tracheostomy.

Risk factors: Bilateral dissection, revision surgery, large goitre, malignancy

Hypocalcaemia — Parathyroid Insufficiency

Most common complication after total thyroidectomy. Results from devascularisation or inadvertent removal of parathyroid glands → fall in PTH → reduced calcium.

Timing

Peak incidence: Day 1-3 post-op
Transient: resolves within 6 months (80-90% of cases)
Permanent: persisting beyond 6 months (1-3%)

Clinical Signs (in order of severity)

Early Perioral (circumoral) numbness, tingling fingertips/toes
Moderate Muscle cramps, carpopedal spasm
Severe Chvostek's sign positive, Trousseau's sign positive
Emergency Laryngospasm, bronchospasm, seizures, tetany
Cardiac Prolonged QT interval → arrhythmia risk

EMERGENCY ALGORITHM: Wound Haematoma / Expanding Neck Swelling ▶

Expanding neck haematoma after thyroid surgery = AIRWAY EMERGENCY. Act within minutes.
Compresses trachea externally — standard orotracheal intubation may become impossible as swelling progresses.

Recognition

Rapidly enlarging neck swelling (often within first 4-6 hours post-op)
Increasing neck tightness reported by patient
Tracheal deviation, respiratory distress, stridor
Haemoserous drainage from wound drain (if in situ)
Hypoxia on pulse oximetry — LATE sign

Immediate Action Algorithm

Call for help immediately — senior nurse, surgeon, anaesthetist, resuscitation team
OPEN THE WOUND AT THE BEDSIDE — do NOT wait to transfer to theatre
Use suture scissors (for sutures) or clip removers (for staples/clips) — these must be kept at the bedside of every post-thyroidectomy patient
Remove skin sutures/clips, then open platysma and strap muscles to decompress haematoma
Apply oxygen; prepare for emergency intubation (may require awake fibreoptic or surgical airway)
Establish IV access, IV fluids, cross-match blood
Transfer to theatre for formal haemostasis under general anaesthesia once airway secured

NURSING STANDARD: Suture scissors AND clip removers must be visible and accessible at the bedside of every post-thyroidectomy patient for the first 24-48 hours. Document their presence in handover.

Common Bleeding Sources

Superior thyroid artery / vein
Inferior thyroid vessels
Thyroid bed venous ooze
Skin edge vessels

Prevention

Careful haemostasis intraoperatively (bipolar diathermy, harmonic scalpel, ligatures)
Avoid Valsalva during extubation
Control post-op hypertension
Wound drains — controversial but common in GCC centres for total thyroidectomy

Chvostek's Sign & Trousseau's Sign — Examination Technique ▶

Chvostek's Sign

Sensitivity ~30% Specificity ~90%

Technique

Patient supine or seated, relaxed facial muscles
Identify the point 2 cm anterior to the ear lobe, just below the zygomatic arch (where the facial nerve exits the parotid)
Tap firmly 2-3 times with fingertip

Positive Result

Ipsilateral facial muscle twitching (orbicularis oris, orbicularis oculi)
Corner of mouth twitches toward ear
Graded 1-4 based on extent of twitching

Mechanism: Hypocalcaemia increases nerve membrane excitability — mechanical stimulation triggers depolarisation.

Note: Can be positive in 10-25% of normal individuals (false positive). Always correlate with serum calcium.

Trousseau's Sign

Sensitivity ~94% Specificity ~99%

Technique

Apply blood pressure cuff to upper arm
Inflate to 20 mmHg above systolic BP
Maintain inflation for 3 minutes
Observe forearm and hand

Positive Result

Carpal spasm (main d'accoucheur — "obstetrician's hand")
Wrist flexion, metacarpophalangeal joint flexion
Interphalangeal joint extension
Adduction of thumb across palm

Mechanism: Ischaemia from cuff inflation + hypocalcaemia → spontaneous neural discharge → carpopedal spasm.

More specific than Chvostek's — preferred clinical test for latent tetany post-thyroidectomy.

Clinical Pearl: Check both signs on admission to post-op ward and then at each nursing assessment (4-hourly for first 24h). Document baseline to detect deterioration. A positive Trousseau's sign with serum Ca <2.0 mmol/L warrants immediate medical review.

Wound & General Post-Op Monitoring

Wound Assessment

Inspect wound every 1-2 hours for first 6 hours
Look for swelling, redness, haematoma, dehiscence
Drain output — record hourly; alert if >50 mL/h
Ensure clip removers/scissors at bedside (document)

Respiratory Assessment

SpO2, respiratory rate, quality of breath sounds
Listen for stridor at each assessment
Head-of-bed elevation 30-45 degrees (reduces oedema, aids breathing)

Voice Assessment

Ask patient to speak and count 1-10 every 2 hours
Note hoarseness, breathiness, volume change
Document and report any new change

Infection Signs

Temperature >38.5°C — blood cultures before antibiotics
Wound erythema, warmth, purulent discharge
WBC elevation
Rare <1% but diabetic/immunosuppressed patients at higher risk

Hypocalcaemia Management

Calcium Monitoring Schedule

Time Period	Monitoring Frequency	Action Threshold
0-24h post-op (Day 1)	4-hourly serum calcium	Start oral calcium if Ca <2.2 mmol/L or symptomatic
24-72h post-op (Days 2-3)	8-hourly serum calcium	IV calcium if Ca <1.9 mmol/L or symptomatic
Day 4 to discharge	Once daily (or per protocol)	Ensure stable on oral supplements before discharge
Outpatient — 1 week	Serum calcium + PTH	Adjust supplementation
6 months	Serum calcium + PTH + Vit D	Permanent vs transient hypoparathyroidism determination

Always check corrected calcium (adjust for albumin): Corrected Ca = Measured Ca + 0.02 × (40 − serum albumin g/L). Or use ionised calcium (gold standard). Normal corrected calcium: 2.2 – 2.6 mmol/L.

Oral Calcium Supplementation

Standard Regimen

Calcium carbonate 1,250 mg (= 500 mg elemental Ca) 2-3 times daily with food (requires gastric acid for absorption)
Total elemental calcium: 1-3 g/day
Calcium citrate (alternative) — can be taken without food; better in achlorhydria/PPI users

Nursing Points

Take with meals (calcium carbonate)
Separate from levothyroxine by at least 4 hours (impairs absorption)
Separate from iron supplements by 2 hours
Constipation is a common side effect — advise fluids and fibre
Ensure patient education before discharge

Active Vitamin D (Alfacalcidol)

Alfacalcidol 0.5–1 mcg daily (1-alpha-hydroxycholecalciferol)
Does not require renal 1-alpha-hydroxylation (bypasses need for PTH-dependent activation)
Or calcitriol 0.25–0.5 mcg twice daily
Monitor serum calcium weekly initially — risk of hypercalcaemia
Dose titrated to keep calcium in low-normal range (2.0–2.3 mmol/L in hypoparathyroidism)

IV Calcium — Symptomatic / Severe Hypocalcaemia

INDICATIONS FOR IV CALCIUM: Symptomatic hypocalcaemia (tetany, laryngospasm, seizure) OR serum Ca <1.8 mmol/L regardless of symptoms.

Acute Bolus

10 mL of 10% calcium gluconate (= 2.25 mmol elemental Ca)
Administer IV over 10 minutes (slow push or infusion)
Do NOT give as rapid IV bolus — risk of cardiac arrhythmia/arrest
Cardiac monitoring required during infusion
Can repeat after 10 minutes if no response

Maintenance Infusion

Add 100 mL of 10% calcium gluconate to 1L of 0.9% NaCl or 5% dextrose
Infuse at 50-100 mL/hour (titrate to response)
Recheck calcium every 4-6 hours
Transition to oral once serum Ca >2.0 mmol/L and symptoms resolved

Important Safety Points

Calcium gluconate preferred over calcium chloride peripherally (less tissue necrosis if extravasation)
Calcium chloride (10 mL 10%) used in cardiac arrest / HDU setting (3x more elemental Ca)
Inspect IV site frequently for extravasation
Incompatible with bicarbonate and phosphate in same line

Hypomagnesaemia — The Hidden Culprit

KEY PRINCIPLE: Hypocalcaemia refractory to calcium supplementation may be caused by concurrent hypomagnesaemia. Correct magnesium FIRST.

Magnesium is required for PTH secretion AND for end-organ PTH receptor sensitivity. Low magnesium blocks both.

Causes Post-Op

Poor oral intake / prolonged fasting
Diarrhoea, vomiting
PPI use (chronic)
Alcoholism, malnutrition
Diabetes mellitus

Management

Check serum magnesium in all post-thyroidectomy patients with hypocalcaemia
Normal: 0.7–1.0 mmol/L
Oral: magnesium glycinate or oxide 200-400 mg/day
IV: magnesium sulphate 20 mmol in 250 mL 0.9% NaCl over 2-4 hours
Monitor deep tendon reflexes if giving IV MgSO4

Permanent vs Transient Hypoparathyroidism

Feature	Transient	Permanent
Definition	Recovers within 6 months	Persistent beyond 6 months
Incidence (total thyroidectomy)	20-40% temporary	1-3% permanent
Cause	Oedema, transient devascularisation, thermal injury	All 4 glands devascularised/removed
PTH level	Low initially, recovers	Persistently undetectable
Management	Short-term supplements, gradual wean	Long-term alfacalcidol + calcium; consider recombinant PTH (Natpara)
6-month review	Trial withdrawal of supplements under monitoring	Lifelong supplementation, annual renal function monitoring (nephrocalcinosis risk)

Post-Thyroidectomy Hypocalcaemia Risk & Monitoring Guide

Enter patient data to receive a personalised action plan based on calcium level and clinical symptoms.

Hours Post-Operation

Serum Calcium (mmol/L)

Symptoms Present (check all that apply)

Tingling / Numbness (perioral or extremities) Muscle cramps Chvostek's sign positive Trousseau's sign positive Stridor / Laryngospasm Seizure / Tetany

Calcium Level Category

—

Symptom Severity

—

Recommended Action

—

Monitoring Frequency

—

Thyroid Cancer & Radioiodine Therapy

Thyroid Cancer Classification

Differentiated Thyroid Cancer (DTC)

Excellent Prognosis 10-year survival >90%

Papillary Thyroid Cancer (PTC) — 80-85%

Most common; arises from follicular cells
Spreads to regional lymph nodes (not a bad prognostic sign)
BRAF V600E mutation common
Multifocal, bilateral common
Excellent response to RAI

Follicular Thyroid Cancer (FTC) — 10-15%

Cannot be distinguished from adenoma by FNAC alone
Haematogenous spread (lung, bone)
RAS / PAX8-PPARγ mutations
Good RAI uptake

Medullary Thyroid Cancer (MTC) — 3-5%

Intermediate Prognosis

Arises from parafollicular C-cells (calcitonin-producing)
Tumour markers: Calcitonin (diagnosis, monitoring), CEA
RET proto-oncogene mutation
25% familial: MEN2A (MTC + phaeochromocytoma + primary HPT), MEN2B (MTC + phaeochromocytoma + marfanoid habitus/mucosal neuromas)
Genetic testing (RET) mandatory in all MTC patients + 1st degree relatives
Does NOT respond to RAI (no iodine uptake in C-cells)

Anaplastic Thyroid Cancer (ATC) — <1%

Very Poor Prognosis Median survival 3-6 months

Most aggressive solid tumour
Rapid local invasion; usually unresectable at diagnosis
Multimodal: surgery (if possible) + radiotherapy + targeted therapy (BRAF/MEK inhibitors if BRAF+ mutation)

Post-Surgical Monitoring for Differentiated Thyroid Cancer

Thyroglobulin (Tg) — Tumour Marker

Produced only by thyroid tissue (follicular cells)
After total thyroidectomy + RAI ablation: should be undetectable
Rising Tg = recurrence / residual disease
Always measure with anti-Tg antibodies (can interfere falsely low)
Stimulated Tg (after TSH stimulation — endogenous withdrawal or recombinant TSH/Thyrogen) more sensitive
Neck USS annually for first 3-5 years

TSH Suppression Therapy

TSH stimulates thyroid cancer cell growth via TSH receptor
High-risk DTC: suppress TSH <0.1 mIU/L with levothyroxine
Low-risk DTC: TSH 0.5–2.0 mIU/L (normal range) acceptable
Side effects of suppression: atrial fibrillation, osteoporosis (especially post-menopausal women)
Bone density monitoring in patients on long-term suppression

Radioactive Iodine (RAI / I-131) Therapy

RAI is used for: (1) Remnant ablation after total thyroidectomy for DTC; (2) Treatment of RAI-avid metastatic DTC; (3) NOT used for MTC or ATC.

Pre-RAI Preparation

TSH Stimulation (required for RAI uptake)

Method 1 — Thyroid hormone withdrawal: Stop levothyroxine 4 weeks before RAI (TSH rises naturally). Patient becomes hypothyroid — significant fatigue, cognitive impairment, fluid retention. Not suitable for some patients.
Method 2 — Recombinant TSH (Thyrogen): Two IM injections day -2 and -1 before RAI. Patient remains euthyroid. Preferred in GCC centres where available.

Low-Iodine Diet (LID)

Commence 2 weeks before RAI
Aim: deplete body iodine stores so thyroid tissue avidly takes up I-131
Avoid: seafood, seaweed, iodised salt, dairy, egg yolks, processed foods, IV contrast agents
GCC-specific: review commercial Arabic food products for hidden iodine

RAI Isolation Nursing Precautions

I-131 is excreted in saliva, urine, sweat, faeces, and breast milk. Radiation protection mandatory.

Single room with en-suite bathroom — door kept closed
Minimum contact time — limit nurse time at bedside; complete all care efficiently
Distance — maintain ≥1 metre when possible; inverse square law
Lead apron where available (supplementary protection)
Dosimetry badge worn by all nursing staff
No pregnant staff or those planning pregnancy within 6 months to care for RAI patients
No children or pregnant visitors for 48-72 hours
Flush toilet 2-3 times after use; wash hands thoroughly
Dedicated toilet paper, tissues, cups — double-bagged waste
Bodily fluid precautions for 48-72 hours (urine especially)
Encourage hydration (flush kidneys) and lemon drops (stimulate saliva flow — reduces salivary gland uptake)
Radiation Safety Officer to advise on specific discharge criteria (based on activity administered)

RAI Isolation Nursing Precautions Checklist ▶

Before RAI Administration

Single room confirmed and prepared
En-suite bathroom available and stocked
Radiation hazard signs posted on door
Patient informed of isolation requirements and duration
Dosimetry badge issued to all staff who will enter
Pregnant staff excluded from care roster
Lead apron available
Double-bag waste bins prepared (labelled radioactive)
Dedicated single-use items provided (cups, tissues, cutlery)
Verify 2-week low-iodine diet compliance
TSH >30 mIU/L confirmed (or recombinant TSH administered)
Written informed consent obtained
Pregnancy test performed (females of childbearing age)
Breastfeeding cessation confirmed (minimum 6 weeks before RAI)

During Isolation (48-72h)

Minimise time at bedside — batch all care
Maintain ≥1 metre distance when possible
Encourage PO fluids (water, non-iodine beverages)
Encourage lemon drops / sour sweets (saliva flow)
Monitor for neck tenderness (radiation thyroiditis)
Flush toilet 2-3 times after each use
Handle soiled linen with gloves, double bag
No sharing of food utensils
Document radiation exposure of staff
Check with radiation safety officer before any procedure

Discharge Criteria (Radiation Safety Officer)

Radiation levels at 1 metre meet local regulatory threshold
Patient education completed (home isolation instructions)
Separate sleeping arrangements >1 week (advice varies by dose)
Avoid pregnant women and children close contact for 1-2 weeks
Return appointment for Tg and scan booked

Parathyroid Surgery

Primary Hyperparathyroidism (PHPT)

Pathophysiology

Excess PTH secretion from one or more parathyroid glands
PTH ↑ → ↑Serum calcium, ↓Phosphate, ↓Urinary calcium excretion
Causes: Solitary adenoma (85%), multigland hyperplasia (10-15%), double adenoma (5%), carcinoma (<1%)
Associated with MEN1 (PHPT + pituitary + pancreatic tumours) and MEN2A

Classic Presentation Mnemonic

"Stones, Bones, Groans, Psychic Moans"
Stones: Renal calculi (calcium oxalate), nephrocalcinosis, polyuria/polydipsia
Bones: Osteoporosis, osteitis fibrosa cystica, pathological fractures, subperiosteal resorption (radial aspect of middle phalanges)
Groans: Nausea, vomiting, constipation, anorexia, peptic ulcers (gastrin-producing)
Psychic Moans: Depression, cognitive impairment, anxiety, psychosis, fatigue

Investigations

Test	Expected Finding
Serum calcium (corrected)	↑ (>2.6 mmol/L)
Intact PTH	↑ (inappropriately elevated)
Serum phosphate	↓
24h urinary calcium	↑ (>400 mg/day)
Alkaline phosphatase	↑ (if bone disease)
Vitamin D (25-OH)	Often ↓ in GCC patients
Creatinine/GFR	May be ↓ (nephrocalcinosis)

Familial Hypocalciuric Hypercalcaemia (FHH): Must be excluded before surgery. FHH = high Ca + high PTH + LOW 24h urine calcium (<200 mg/day). Calcium:creatinine clearance ratio <0.01 suggests FHH — surgery not helpful.

Pre-Operative Localisation

Sestamibi Scan (99mTc-MIBI)

First-line localisation; identifies hyperfunctioning gland
Sensitivity ~80% for single adenoma
Poor for multigland disease
SPECT-CT improves anatomical localisation
Ectopic glands (mediastinal, intrathyroidal) well identified

Ultrasound (USS) Neck

First-line adjunct to sestamibi
Identifies enlarged gland in neck, relationship to thyroid
Cannot visualise mediastinal glands
Operator-dependent
Combined sestamibi + USS concordant: sufficient for MIP
4D-CT or MRI parathyroid if discordant or re-operative case

Surgical Approaches

Minimally Invasive Parathyroidectomy (MIP)

Small (2-3 cm) focused unilateral incision
Requires concordant pre-op localisation
Requires intraoperative PTH monitoring (ioPTH)
Benefits: shorter surgery, less scarring, day case possible
Cure rate 97-99% when combined with ioPTH

Intraoperative PTH Monitoring (ioPTH) — Miami Criterion

CURE CRITERION: PTH falls by >50% from highest pre-excision value AND enters normal range within 10 minutes of gland removal.
If this is not met → convert to bilateral neck exploration (suspect multigland disease).

Bilateral Neck Exploration (BNE)

Traditional approach; explores all four glands
Required for: multigland disease, MEN1/2A, failed MIP, re-operative cases, non-localising imaging
Higher risk of RLN injury and permanent hypoparathyroidism
Gold standard for familial disease

Indications for Surgery in PHPT

Symptomatic PHPT (stones, osteoporosis, symptoms)
Asymptomatic: Ca >2.85 mmol/L, age <50, T-score <-2.5, GFR <60, 24h urine Ca >400 mg/day
Patient preference after informed discussion

Post-Operative Hypocalcaemia — Hungry Bone Syndrome

HUNGRY BONE SYNDROME: After cure of longstanding PHPT, the skeleton is depleted of calcium. With PTH suddenly removed, bones avidly absorb calcium from the bloodstream → precipitous, severe, prolonged hypocalcaemia.

Risk Factors

Longstanding, severe PHPT
High preoperative ALP (bone turnover marker)
Osteitis fibrosa cystica on imaging
Very high pre-op PTH levels
Concurrent vitamin D deficiency (common in GCC)

Management

Pre-load vitamin D pre-operatively (correct deficiency first)
High-dose oral calcium: 3-6 g elemental calcium/day
Alfacalcidol 1-2 mcg/day (higher doses than thyroidectomy)
IV calcium infusion may be needed for days–weeks
Monitor calcium every 4-6 hours initially
Magnesium supplementation often needed
May require prolonged inpatient stay

Parathyroid Carcinoma

Rare (<1% of PHPT). Distinguished from adenoma by capsular and vascular invasion on histology. Associated with HRPT2/CDC73 gene mutation.

Clinical Features Suggesting Malignancy

Very high calcium (>3.5 mmol/L)
Very high PTH (>5× normal)
Palpable neck mass (unusual in benign PHPT)
Concurrent renal and bone disease
Intraoperative: hard, adherent, grey-white gland

Treatment

En-bloc resection: parathyroid gland + ipsilateral thyroid lobe + adjacent lymph nodes
Do NOT rupture capsule intraoperatively (seeds recurrence)
No effective systemic therapy — surgery only curative option
Cinacalcet (calcimimetic) for unresectable/recurrent disease — controls hypercalcaemia
Lifelong monitoring: serum calcium + intact PTH

GCC Clinical Context & Nursing Competencies

Thyroid Cancer Epidemiology in the GCC

Incidence Data

UAE and Saudi Arabia rank among the highest thyroid cancer incidence rates globally per 100,000 population
Thyroid cancer is among the top 5 cancers in females in UAE and KSA
Papillary thyroid cancer overwhelmingly predominates
Higher rates partly explained by increased USS surveillance, incidentaloma detection, and obesity rates

Historical Role of Iodine Deficiency

Pre-iodisation era: iodine deficiency drove MNG and follicular cancer prevalence in GCC
Salt iodisation programmes introduced in most GCC countries from 1990s onwards
Paradoxically, iodisation may increase papillary (not follicular) cancer detection
Residual iodine deficiency still seen in certain rural/expatriate populations

GCC-Specific Risk Factors

Vitamin D deficiency — despite abundant sunshine — affects 60-80% of GCC population
Cultural factors: full-body covering clothing reduces UVB skin exposure
Indoor lifestyle (air conditioning), high SPF sunscreen use
Darker skin phenotype requires longer UVB exposure for equivalent Vitamin D synthesis
Dietary sources insufficient to compensate
Clinical impact: Vitamin D deficiency compounds post-thyroidectomy/parathyroidectomy hypocalcaemia risk significantly
Obesity rates in GCC (Kuwait, Bahrain, Qatar >40% adult prevalence) — association with thyroid cancer
Radiation exposure history (Chernobyl-era expatriates in GCC workforce)

GCC Regulatory & Licensing Bodies — Nursing

Body	Country	Relevance to Thyroid/Surgical Nursing
DHA (Dubai Health Authority)	Dubai, UAE	Perioperative nursing competency framework; scope of practice for post-op monitoring including calcium management
DOH (Department of Health)	Abu Dhabi, UAE	HAAD-equivalent nursing exam; clinical privileges for perioperative nurses
MOH UAE	Federal UAE	Northern Emirates nursing registration and scope
SCFHS (Saudi Commission for Health Specialties)	Saudi Arabia	Perioperative nursing certification; Saudi Nursing Board exam; Tamheed exam for international nurses
QCHP (Qatar Council for Healthcare Practitioners)	Qatar	Nursing registration exam; Prometric-based MCQ assessment
MOH Kuwait / Bahrain / Oman	Kuwait / Bahrain / Oman	Country-specific registration exams; perioperative competency frameworks

SCFHS Perioperative Nursing Certification: Requires documented competency in post-thyroidectomy monitoring including: calcium assessment, Chvostek/Trousseau examination, haematoma emergency response, and wound care. DHA exams commonly feature thyroid surgery complications in perioperative nursing modules.

Patient Education — Levothyroxine Compliance in GCC

Standard Levothyroxine Counselling

Take on an empty stomach, 30-60 minutes before breakfast
Do not take with calcium supplements, iron, antacids, or dairy (chelate and reduce absorption)
Take at the same time every day
TSH check every 6 weeks initially, then annually when stable
Signs of under-treatment: fatigue, weight gain, constipation, cold intolerance, myxoedema
Signs of over-treatment: palpitations, heat intolerance, anxiety, osteoporosis, AF risk

Ramadan Considerations

Ramadan Levothyroxine Timing: Patients fast from dawn (Fajr) to sunset (Maghrib). Options:

Option 1 (Preferred): Take levothyroxine at Suhoor (pre-dawn meal), at least 30-60 minutes before eating — most closely mimics standard morning fasting administration
Option 2: Take at Iftar (sunset) on empty stomach before meal — also acceptable but some evidence of slightly reduced absorption variability
Avoid taking at meal time (significantly impairs absorption)
TSH check 6-8 weeks after Ramadan — dose adjustment may be needed
Advise patients proactively — do not skip doses during Ramadan

Calcium Supplements — Ramadan Timing

Oral calcium at Iftar (with first meal) and Suhoor (with pre-dawn meal)
Separate from levothyroxine by minimum 2 hours
Active vitamin D (alfacalcidol) can be taken with either meal
Ensure adequate fluid intake during non-fasting hours (stone prevention)

Vitamin D Deficiency — GCC Post-Op Implications

GCC NURSING ALERT: Up to 60-80% of GCC patients presenting for thyroid or parathyroid surgery have vitamin D deficiency (25-OH Vit D <50 nmol/L). This significantly amplifies post-operative hypocalcaemia risk and severity.

Vitamin D Deficiency Severity

25-OH Vitamin D Level	Classification
<25 nmol/L (<10 ng/mL)	Severe deficiency
25-50 nmol/L (10-20 ng/mL)	Moderate deficiency
50-75 nmol/L (20-30 ng/mL)	Insufficiency
>75 nmol/L (>30 ng/mL)	Sufficient

Pre-Operative Optimisation Strategy

Check 25-OH Vitamin D at pre-op assessment (minimum 4-6 weeks before elective surgery)
If deficient: loading dose cholecalciferol (Vitamin D3) 40,000-60,000 IU weekly for 8 weeks, then maintenance 2,000-4,000 IU daily
Recheck level before surgery — target >75 nmol/L
Document in surgical referral letter
Post-op: combine cholecalciferol with alfacalcidol in deficient patients

GCC Exam Preparation — DHA / MOH / SCFHS / QCHP Style MCQs

Click "Show Answer" after selecting your answer. These questions reflect the style and content of GCC nursing licensing examinations.

Q1. A patient undergoes total thyroidectomy for Graves' disease. Six hours post-operatively, the nurse notes a rapidly expanding neck swelling and the patient reports difficulty breathing. What is the MOST immediate nursing action?

A. Administer IV calcium gluconate and call the physician
B. Apply ice pack to the neck and monitor oxygen saturation
C. Open the wound at the bedside using suture scissors or clip removers
D. Prepare for emergency tracheostomy and transfer to theatre

Correct Answer: C
An expanding neck haematoma post-thyroidectomy is a surgical airway emergency. The wound must be opened at the bedside immediately to decompress the haematoma before airway obstruction becomes complete. This is why suture scissors and clip removers must always be at the bedside of every post-thyroidectomy patient. Transfer to theatre follows once the airway is secured. IV calcium is for hypocalcaemia, not haematoma.

Q2. A 42-year-old woman had a total thyroidectomy 18 hours ago. Her serum calcium is 1.85 mmol/L. She reports tingling around her lips and muscle cramps. Blood pressure cuff inflated above systolic for 3 minutes elicits carpopedal spasm. Which sign is being demonstrated and what is the FIRST-LINE treatment?

A. Chvostek's sign; oral calcium carbonate with food
B. Trousseau's sign; IV magnesium sulphate infusion
C. Trousseau's sign; IV calcium gluconate 10 mL 10% over 10 minutes
D. Chvostek's sign; IV furosemide to promote calcium reabsorption

Correct Answer: C
The description of carpopedal spasm induced by BP cuff inflation above systolic for 3 minutes is Trousseau's sign (not Chvostek's, which is facial nerve tapping). With symptomatic hypocalcaemia (tingling, cramps, Trousseau positive) and calcium of 1.85 mmol/L, the correct treatment is IV calcium gluconate 10 mL of 10% solution over 10 minutes. Oral calcium is insufficient for symptomatic hypocalcaemia at this level. Furosemide promotes calcium excretion (used in hypercalcaemia — the opposite).

Q3. A nurse in a GCC hospital is preparing a patient for radioactive iodine (RAI/I-131) therapy after total thyroidectomy for papillary thyroid cancer. Which dietary instruction should have been given to the patient for the TWO WEEKS prior to RAI?

A. High-protein, low-fat diet to improve drug metabolism
B. Low-iodine diet — avoid seafood, iodised salt, dairy, egg yolks, and processed foods
C. High-calcium diet to prevent post-RAI hypocalcaemia
D. Low-fibre diet to enhance gastrointestinal iodine absorption

Correct Answer: B
A low-iodine diet for 2 weeks before RAI therapy depletes the body's iodine stores, making any remaining thyroid tissue (and cancer cells) iodine-hungry. This maximises uptake of the therapeutic I-131 dose. Patients must avoid all high-iodine foods: seafood, seaweed, dairy, egg yolks, iodised salt, and many processed foods. In GCC context, patients should also be counselled about iodine in commercial Arabic food products. The calcium and protein dietary advice is not relevant to RAI preparation.

Q4. A Saudi patient who underwent parathyroidectomy for primary hyperparathyroidism now presents on post-operative day 3 with severe symptomatic hypocalcaemia requiring high doses of IV and oral calcium, seemingly refractory to supplementation. Pre-operative alkaline phosphatase was markedly elevated. What is the MOST likely diagnosis?

A. Permanent hypoparathyroidism from inadvertent parathyroid removal
B. Hungry bone syndrome
C. Hypomagnesaemia-induced PTH resistance
D. Vitamin D toxicity from pre-operative supplementation

Correct Answer: B
Hungry bone syndrome occurs after cure of longstanding primary hyperparathyroidism. The skeleton, chronically depleted of calcium due to PTH-driven bone resorption, avidly absorbs calcium once PTH is removed — causing precipitous, severe, and prolonged hypocalcaemia. Markedly elevated pre-operative ALP is a key predictor (indicates high bone turnover). While hypomagnesaemia should also be checked and corrected (Option C is partly relevant), the primary diagnosis here is hungry bone syndrome. This is especially common in GCC patients who often present late with advanced bone disease.

Q5. During Ramadan, a post-thyroidectomy patient (on levothyroxine + calcium carbonate) asks the nurse when to take their medications while fasting. What is the MOST appropriate advice for levothyroxine timing?

A. Skip levothyroxine during Ramadan as fasting is mandatory for all medications
B. Take levothyroxine at Iftar time with the first meal to improve absorption
C. Take levothyroxine at Suhoor (pre-dawn meal time), at least 30-60 minutes before eating
D. Take levothyroxine with calcium carbonate at Iftar simultaneously for convenience

Correct Answer: C
Levothyroxine must be taken on an empty stomach, 30-60 minutes before food, for optimal absorption. During Ramadan, Suhoor (pre-dawn, before Fajr) provides the best opportunity — the patient takes levothyroxine at least 30-60 minutes before the Suhoor meal. This most closely mimics the standard morning fasting regimen. Option B (with Iftar meal) significantly reduces absorption. Option D is incorrect because calcium carbonate chelates levothyroxine and must be separated by at least 2-4 hours. Never advise skipping medication during Ramadan — Islamic scholarship permits medication for medical necessity.